NCT04302012View on ClinicalTrials.gov

Assessment of EyeArt Performance With Retinal Imaging Devices

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

December 18, 2019

Primary Completion Date

February 27, 2020

Study Completion Date

February 27, 2020

Conditions
Diabetic Retinopathy
Interventions
PROCEDURE

Color fundus photography

Subjects will undergo fundus photography before and/or after administration of mydriatic agent

DRUG

Mydriatic Agent

Subjects may be administered mydriatic medication to dilate their pupils.

Trial Locations (1)

90502

Lundquist Institute, Los Angeles

All Listed Sponsors
lead

Eyenuk, Inc.

INDUSTRY

NCT04302012 - Assessment of EyeArt Performance With Retinal Imaging Devices | Biotech Hunter | Biotech Hunter